DaShenLin Pharmaceutical Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002RG2
CNY
18.55
0.06 (0.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
6,973.25
7,433.94
6,545.67
6,566.57
6,956.00
6,765.54
6,385.66
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,973.25
7,433.94
6,545.67
6,566.57
6,956.00
6,765.54
6,385.66
Raw Material Cost
4,459.74
5,112.87
4,402.30
4,416.19
4,654.11
4,664.06
4,353.07
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
35.06
40.14
45.81
50.42
53.00
73.19
51.78
Selling and Distribution Expenses
1,748.02
1,842.03
1,642.64
1,625.28
1,599.33
1,855.09
1,693.33
Other Expenses
-2.54
-4.01
-2.94
-3.01
-4.45
-7.03
-3.44
Total Expenditure (Excl Depreciation)
6,217.39
6,954.89
6,061.32
6,061.80
6,261.98
6,522.08
6,063.76
Operating Profit (PBDIT) excl Other Income
755.9000000000001
479
484.4
504.79999999999995
694
243.5
321.9
Other Income
18.66
24.48
2.30
37.69
33.51
67.06
32.79
Operating Profit (PBDIT)
742.33
868.71
885.06
979.99
1,155.04
747.55
822.13
Interest
35.06
40.14
45.81
50.42
53.00
73.19
51.78
Exceptional Items
-0.25
-60.13
0.19
1.17
3.68
-23.05
-0.99
Gross Profit (PBDT)
2,513.51
2,321.08
2,143.37
2,150.38
2,301.90
2,101.47
2,032.58
Depreciation
0.00
441.14
441.14
456.30
456.30
490.92
490.92
Profit Before Tax
707.02
327.29
398.31
474.43
649.42
160.39
278.43
Tax
163.45
128.00
95.80
115.00
151.74
94.51
65.47
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
511.14
154.25
282.83
338.17
460.00
56.63
200.53
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
511.14
154.25
282.83
338.17
460.00
56.63
200.53
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
32.43
45.05
19.68
21.26
37.68
9.25
12.43
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
543.57
199.30
302.51
359.43
497.68
65.88
212.96
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
7,871.39
7,367.78
7,229.65
7,331.74
7,356.42
6,897.24
6,870.20
Earnings per share (EPS)
0.45
0.14
0.25
0.3
0.41
0.05
0.18
Diluted Earnings per share
0.45
0.14
0.25
0.3
0.41
0.05
0.18
Operating Profit Margin (Excl OI)
10.38%
5.42%
6.75%
7.4%
9.56%
2.8%
4.67%
Gross Profit Margin
10.14%
10.34%
12.82%
14.17%
15.9%
9.63%
12.05%
PAT Margin
7.33%
2.07%
4.32%
5.15%
6.61%
0.84%
3.14%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 0.25% vs 3.02% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 9.22% vs 9.70% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -35.47% vs 5.71% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -33.77% vs -14.79% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of DaShenLin Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
6,973.25
0
6,973.25
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,973.25
0
6,973.25
Raw Material Cost
4,459.74
0
4,459.74
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
35.06
0
35.06
Selling and Distribution Expenses
1,748.02
0
1,748.02
Other Expenses
-2.54
0.00
-2.54
Total Expenditure (Excl Depreciation)
6,217.39
0
6,217.39
Operating Profit (PBDIT) excl Other Income
755.86
0.00
755.86
Other Income
18.66
0
18.66
Operating Profit (PBDIT)
742.33
0
742.33
Interest
35.06
0
35.06
Exceptional Items
-0.25
0
-0.25
Gross Profit (PBDT)
2,513.51
0
2,513.51
Depreciation
0.00
0
0.00
Profit Before Tax
707.02
0
707.02
Tax
163.45
0
163.45
Provisions and contingencies
0
0
0.00
Profit After Tax
511.14
0
511.14
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
511.14
0
511.14
Share in Profit of Associates
0
0
0.00
Minority Interest
32.43
0
32.43
Other related items
0.00
0.00
0.00
Consolidated Net Profit
543.57
0
543.57
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
7,871.39
0
7,871.39
Earnings per share (EPS)
0.45
0
0.45
Diluted Earnings per share
0.45
0
0.45
Operating Profit Margin (Excl OI)
10.38%
0%
0.00
10.38%
Gross Profit Margin
10.14%
0%
0.00
10.14%
PAT Margin
7.33%
0%
0.00
7.33%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 697.32 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -6.20% vs 13.57% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 0.25% vs 3.02% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 54.36 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 172.75% vs -34.12% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 9.22% vs 9.70% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 72.37 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -14.27% vs -4.37% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -35.47% vs 5.71% in Mar 2025

Quarterly - Interest
Interest 3.51 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -12.47% vs -12.45% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -33.77% vs -14.79% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.38%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025